Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-19
DOI
10.1038/s41416-022-01811-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
- (2021) Carl M. Gay et al. CANCER CELL
- Small cell lung cancer enters the era of precision medicine
- (2021) Kristopher K. Frese et al. CANCER CELL
- Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation
- (2021) Yukiko Kiniwa et al. BMC CANCER
- Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide
- (2021) Landon C. Brown et al. CLINICAL CANCER RESEARCH
- Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study
- (2021) Lauren Averett Byers et al. CLINICAL CANCER RESEARCH
- A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers
- (2021) Bingnan Zhang et al. BRITISH JOURNAL OF CANCER
- Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer
- (2021) H.I. Scher et al. EUROPEAN JOURNAL OF CANCER
- Molecular Subtypes of Primary Small Cell Lung Cancer Tumors and Their Associations with Neuroendocrine and Therapeutic Markers
- (2021) Song Qu et al. Journal of Thoracic Oncology
- SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer
- (2021) Claudia Winkler et al. JCI Insight
- SLFN11 expression in advanced prostate cancer and response to platinum-based chemotherapy
- (2020) Vincenza Conteduca et al. MOLECULAR CANCER THERAPEUTICS
- MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
- (2020) Abbie S. Ireland et al. CANCER CELL
- Morphology-predicted large scale transition number in circulating tumor cells identifies a chromosomal instability biomarker associated with poor outcome in castration-resistant prostate cancer
- (2020) Joseph D. Schonhoft et al. CANCER RESEARCH
- SLFN11 informs on standard of care and novel treatments in a wide range of cancer models
- (2020) Claudia Winkler et al. BRITISH JOURNAL OF CANCER
- Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
- (2019) Loredana Puca et al. Science Translational Medicine
- SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing
- (2019) Riccardo Mezzadra et al. PLoS One
- Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
- (2019) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial
- (2019) R Y Tay et al. ANNALS OF ONCOLOGY
- Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
- (2019) Stephanie N. Shishido et al. Journal of Translational Medicine
- Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
- (2018) M. Catherine Pietanza et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer
- (2018) Howard I. Scher et al. JAMA Oncology
- The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases
- (2017) Erik Thunnissen et al. Journal of Thoracic Oncology
- Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer
- (2017) C. Allison Stewart et al. Oncotarget
- Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
- (2016) Junko Murai et al. Oncotarget
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer
- (2015) H. Beltran et al. CLINICAL CANCER RESEARCH
- Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity
- (2015) Fabricio G. Sousa et al. DNA REPAIR
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- (2014) Cassandra L Hodgkinson et al. NATURE MEDICINE
- The Schlafen Family of Proteins and Their Regulation by Interferons
- (2013) Evangelos Mavrommatis et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
- (2012) Jian-Mei Hou et al. JOURNAL OF CLINICAL ONCOLOGY
- Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas
- (2012) William D Travis MODERN PATHOLOGY
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents
- (2012) G. Zoppoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started